As the GLP-1 landscape evolves, understanding its wide-ranging societal impacts is more important than ever
- y l sn phm chuyn dng, s dng 2-3 ngy 1 ln ty theo c a mi ngi.
#BioScienceCareerCompass #MetabolicHealth #PharmaTrends #LifeSciences To view or add a comment, sign in Check out this Highly Cited Paper: New Developments in Pharmacological Treatment of Obesity and Type 2 DiabetesBeyond and within GLP-1 Receptor Agonists by Sztanek, F., et al
Introduction The majority of peptides that have been discussed up until this point have originated in the pituitary, gut, or connective tissue
This allows multiple withdrawals from the same vial
The immense market potential of small molecule GLP-1R agonists, coupled with intense R&D competition, is likely to result in even more fast-followers